Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

The safety of warfarin therapy in the nursing home setting.

Gurwitz JH, Field TS, Radford MJ, Harrold LR, Becker R, Reed G, DeBellis K, Moldoff J, Verzier N.

Am J Med. 2007 Jun;120(6):539-44. Epub 2007 Apr 26.

PMID:
17524757
2.
3.

Use of specific indicators to detect warfarin-related adverse events.

Hartis CE, Gum MO, Lederer JW Jr.

Am J Health Syst Pharm. 2005 Aug 15;62(16):1683-8. Review.

PMID:
16085930
4.

Warfarin therapy in older adults: managing treatment in the primary care setting.

Perrero PP, Willoughby DF, Eggert JA, Counts SH.

J Gerontol Nurs. 2004 Jul;30(7):44-54. Review.

PMID:
15287326
5.

Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care.

Thomsen LA, Winterstein AG, Søndergaard B, Haugbølle LS, Melander A.

Ann Pharmacother. 2007 Sep;41(9):1411-26. Epub 2007 Jul 31. Review.

PMID:
17666582
6.

Improving the safety profile of warfarin.

Chai SJ, Macik BG.

Semin Hematol. 2002 Jul;39(3):179-86. Review.

PMID:
12124680
7.

[Patient safety and risk management].

Schrappe M.

Med Klin (Munich). 2005 Aug 15;100(8):478-85. Review. German.

PMID:
16096729
8.

Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.

Phillips KW, Ansell J.

Expert Rev Cardiovasc Ther. 2008 Jan;6(1):57-70. Review.

PMID:
18095907
9.

Known knowns and known unknowns: risks associated with combination antithrombotic therapy.

Johnson S.

Thromb Res. 2008;123 Suppl 1:S7-11. doi: 10.1016/j.thromres.2008.08.011. Epub 2008 Oct 1. Review.

PMID:
18829070
10.

What to do when warfarin therapy goes too far.

Prasad S, Wootten MR, Kulinski N, Chapman SA.

J Fam Pract. 2009 Jul;58(7):346-52. Review.

PMID:
19607771
11.

Nature of preventable adverse drug events in hospitals: a literature review.

Kanjanarat P, Winterstein AG, Johns TE, Hatton RC, Gonzalez-Rothi R, Segal R.

Am J Health Syst Pharm. 2003 Sep 1;60(17):1750-9. Review.

PMID:
14503111
12.

Interaction potential between cranberry juice and warfarin.

Pham DQ, Pham AQ.

Am J Health Syst Pharm. 2007 Mar 1;64(5):490-4. Review.

PMID:
17322161
14.

Potential risks and prevention, Part 3: Drug-induced threats to life.

Marcellino K, Kelly WN.

Am J Health Syst Pharm. 2001 Aug 1;58(15):1399-405. Review.

PMID:
11494784
15.

Epidemiology of adverse drug events in the nursing home setting.

Monette J, Gurwitz JH, Avorn J.

Drugs Aging. 1995 Sep;7(3):203-11. Review.

PMID:
8535050
16.

Epidemiology of medication-related adverse events in nursing homes.

Handler SM, Wright RM, Ruby CM, Hanlon JT.

Am J Geriatr Pharmacother. 2006 Sep;4(3):264-72. Review.

PMID:
17062328
17.

Quality improvement case study: warfarin sodium interactions.

Weinberg AD, Altman JS, Pals JK.

J Am Med Dir Assoc. 2006 Jun;7(5):315-8. Review.

PMID:
16765868
18.

Medication errors--warfarin.

Bird S.

Aust Fam Physician. 2003 Dec;32(12):1003-4. Review. No abstract available.

PMID:
14708149
19.

Warfarin and herbal supplements. A volatile combination.

Ezbianski AA.

Adv Nurse Pract. 2003 Nov;11(11):77-80. Review. No abstract available.

PMID:
14639889
20.

Prescribing for older people in nursing homes: a review of the key issues.

Parsons C, Lapane K, Kerse N, Hughes C.

Int J Older People Nurs. 2011 Mar;6(1):45-54. doi: 10.1111/j.1748-3743.2010.00264.x. Review.

Supplemental Content

Support Center